Type 2 diabetes linked to higher risk of stroke and CV problems; metabolic syndrome isn't

June 13, 2011

Among patients who have had an ischemic stroke or transient ischemic attack (TIA), type 2 diabetes was associated with an increased risk of recurrent stroke or cardiovascular events, but metabolic syndrome was not, according to a report published Online First today by Archives of Neurology.

Previous research has examined the association between cardiovascular incidents and these conditions, according to background information in the article. " is associated with increased risks of both stroke and (CHD)," the authors write. "Metabolic syndrome (MetS) or identifies individuals at higher risk for developing type 2 diabetes and is also associated with an increase in stroke and ."

Alfred Callahan, M.D., from Vanderbilt University, Nashville, and colleagues evaluated these risks as part of a secondary analysis of the Stroke Prevention by Aggressive Reduction of (SPARCL) Trial. The primary goal of that study was to evaluate the effect of a cholesterol-lowering statin drug (atorvastatin) on reducing the incidence of stroke in patients with a prior stroke or TIA. For this study, the authors performed a secondary analysis on the data to determine the risk of or cardiovascular events in patients with type 2 diabetes or MetS, and whether atorvastatin affected those risks.

In total, the study included 4,731 participants who had experienced an or TIA. When enrollment began, researchers classified 794 individuals as having type 2 diabetes, 642 as having MetS and the remaining 3,295 as having neither condition. The endpoints used for this analysis were recurrence of stroke, major coronary or cardiovascular events, any CHD event and any revascularization procedure (a procedure, such as angioplasty, to open a blocked artery).

Patients with type 2 diabetes were more likely than those in the control group to experience another stroke, major cardiovascular incident, or revascularization procedure. Those in the MetS group were not at increased risk of stroke or major cardiovascular events, but were more likely than those in the control group to undergo revascularization procedures. Treatment with the statin medication did significantly reduce the risk of these events in participants with type 2 diabetes or MetS.

The authors note that their results are similar to other studies of stroke and cardiovascular events in individuals with MetS or type 2 diabetes. In particular, they cite the differences in risks between the two conditions. They also point out that statin use did seem to be protective for participants: "Although the possibility of variation in the benefit of statin treatment in subjects with or without type 2 diabetes or MetS cannot be excluded by this analysis, there was no evidence of a difference in treatment effect."

More information: Arch Neurol. 2011;doi:10.1001/archneurol.2011.146

Related Stories

Recommended for you

Erasing unpleasant memories with a genetic switch

June 30, 2016

Researchers from KU Leuven (Belgium) and the Leibniz Institute for Neurobiology (Germany) have managed to erase unpleasant memories in mice using a 'genetic switch'. Their findings were published in Biological Psychiatry.

Motivation to bully is regulated by brain reward circuits

June 29, 2016

Individual differences in the motivation to engage in or to avoid aggressive social interaction (bullying) are mediated by the basal forebrain, lateral habenula circuit in the brain, according to a study conducted at the ...

New clues about the aging brain's memory functions

June 29, 2016

A European study led by Umeå University Professor Lars Nyberg, has shown that the dopamine D2 receptor is linked to the long-term episodic memory, which function often reduces with age and due to dementia. This new insight ...

New technology could deliver drugs to brain injuries

June 28, 2016

A new study led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) describes a technology that could lead to new therapeutics for traumatic brain injuries. The discovery, published today in Nature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.